1. Home
  2. XOS vs RGNT Comparison

XOS vs RGNT Comparison

Compare XOS & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xos Inc.

XOS

Xos Inc.

HOLD

Current Price

$1.85

Market Cap

20.4M

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$2.40

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XOS
RGNT
Founded
2016
2004
Country
United States
Israel
Employees
101
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
20.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XOS
RGNT
Price
$1.85
$2.40
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
18.8K
3.3K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$29.02
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.60
$2.70
52 Week High
$5.60
$8.35

Technical Indicators

Market Signals
Indicator
XOS
RGNT
Relative Strength Index (RSI) 57.57 25.97
Support Level $1.74 N/A
Resistance Level $1.89 $3.35
Average True Range (ATR) 0.09 0.19
MACD 0.03 -0.01
Stochastic Oscillator 95.50 15.38

Price Performance

Historical Comparison
XOS
RGNT

About XOS Xos Inc.

Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Class 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: